Seven Eight Capital’s Inovio Pharmaceuticals INO Stock Holding History

Seven Eight Capital’s Portfolio INO Stock Details INO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-16,363	Closed	-$980K	–	613
2021 Q4	$980K	Sell	16,363 -12,172	-43%	-$975K	0.18%	172
2021 Q3	$2.45M	Buy	28,535 +18,679	+190%	+$1.87M	0.24%	139
2021 Q2	$1.1M	Sell	9,856 -18,361	-65%	-$1.76M	0.15%	233
2021 Q1	$3M	Hold	28,217	–	–	0.69%	29
2020 Q4	$3M	Buy	28,217 +26,545	+1,588%	+$3.53M	0.68%	29
2020 Q3	$233K	Buy	+1,672	New	+$349K	0.05%	494

Other funds holding INO

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Seven Eight Capital's INO Position: Q1 2022 in Review

Seven Eight Capital sold out of Inovio Pharmaceuticals (INO) in Q1 2022, closing a stake of 16,363 shares — an estimated $980K sold.

Seven Eight Capital first reported a position in INO in Q3 2020 and held it in 6 quarters. The position peaked at $3M in Q1 2021. 198 funds tracked by Wall St. Rank hold INO as of Q1 2022.

Seven Eight Capital reported no remaining Inovio Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
Seven Eight Capital sold 16,363 Inovio Pharmaceuticals shares in Q1 2022, an estimated $980K.
Seven Eight Capital first reported a position in Inovio Pharmaceuticals in Q3 2020 and held it in 6 quarters.
Seven Eight Capital's Inovio Pharmaceuticals position peaked at $3M in Q1 2021.
198 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q1 2022.

Based on Seven Eight Capital's 13F filing for Q1 2022, filed 11 May 2022.